Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naive patients with type 2 diabetes - Foley, J E; Sreenan, S (Horm Metab Res, 2009)